Healthpeak director granted 9,744 company shares
Lewis Sara Grootwassink reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Lewis Sara Grootwassink reported acquisition or exercise transactions in this Form 4 filing.
HEALTHPEAK PROPERTIES, INC. director Sara Grootwassink Lewis reported an equity compensation grant. She received 9,744 shares of Common Stock as a grant or award on May 6, 2026, bringing her directly held shares to 56,488.
The award represents restricted stock units that vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the company’s next annual meeting of stockholders. She also reports indirect holdings of 9,000 shares in an IRA and 22,000 shares held through a trust.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 9,744 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Restricted stock units vest in full on the earlier of the first anniversary of the May 6, 2026 grant date or the Company's next annual meeting of stockholders.
Key Figures
Key Terms
Restricted stock units financial
IRA financial
Trust financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Sara Grootwassink Lewis report in this HEALTHPEAK PROPERTIES (DOC) Form 4?
When do the restricted stock units granted to the HEALTHPEAK PROPERTIES (DOC) director vest?
What indirect HEALTHPEAK PROPERTIES (DOC) holdings does the director report?
AI-generated analysis. How Rhea-AI works. Not financial advice.